AB Science S.A. (0Q77)
LSE
Real-time Data
07:00 AM
Day's Range
0.715052 wk Range
0.5400Overview - 0Q77 - AB Science S.A.
Key Statistics
Valuation
Enterprise Value
61.55M
P/E (Trailing)
‪-71.49‬
EV / EBITDA
‪82.62‬
Profitability
Profit Margin
‪-132.62%‬
Operating Margin
‪510.92%‬
Return on Assets
‪1.67%‬
Return on Equity
‪-6.76%‬
Ownership
Shares Outstanding
41.06M
Float
18.11M
Held by Insiders
‪47.70%‬
Held by Institutions
‪0.0030%‬
Price stats
Beta
‪1.16‬
50-Day Avg
‪3.15‬
200-Day Avg
‪3.21‬
Market Cap - 0Q77 - AB Science S.A.
Peers - 0Q77 - AB Science S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0Q77LSEAB Science S.A.28.37MMarket Cap-90.99%52-week change-66.60P/E (Trailing)‪-132.62%‬Profit Margin
- HLNLSEHaleon plc3.25TMarket Cap+1.98%52-week change20.53P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change18.82P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc341.00BMarket Cap+2.60%52-week change—P/E (Trailing)‪-10.78%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB168.30BMarket Cap+37.06%52-week change47.81P/E (Trailing)‪15.54%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited159.03BMarket Cap-23.50%52-week change178.00P/E (Trailing)‪3.25%‬Profit Margin
- 0O14LSEMerck KGaA64.57BMarket Cap+22.53%52-week change19.55P/E (Trailing)‪13.95%‬Profit Margin
Profile Summary - 0Q77 - AB Science S.A.
About
AB Science S.A. is a clinical-stage pharmaceutical company headquartered in Paris, France, founded in 2001. It specializes in the research, design, development, and marketing of innovative drugs targeting diseases with high unmet medical needs, particularly in oncology, inflammatory diseases, and neurological…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
